GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Upstream Bio Inc (NAS:UPB) » Definitions » Other Current Payables

UPB (Upstream Bio) Other Current Payables : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Upstream Bio Other Current Payables?

Upstream Bio's Other Current Payables for the quarter that ended in Dec. 2024 was $0.00 Mil.


Upstream Bio Other Current Payables Historical Data

The historical data trend for Upstream Bio's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Upstream Bio Other Current Payables Chart

Upstream Bio Annual Data
Trend Dec22 Dec23 Dec24
Other Current Payables
- - -

Upstream Bio Quarterly Data
Dec22 Sep23 Dec23 Jun24 Sep24 Dec24
Other Current Payables Get a 7-Day Free Trial - - - - -

Upstream Bio Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Upstream Bio Other Current Payables Related Terms

Thank you for viewing the detailed overview of Upstream Bio's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Upstream Bio Business Description

Traded in Other Exchanges
N/A
Address
890 Winter Street, Suite 200, Waltham, MA, USA, 02451
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.